TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Assets Average (2020 - 2026)

TAO Synergies' (TAOX) quarterly Assets Average came in at $26.1 million in Q2 2026, up 48.49% on a YoY basis from $17.6 million in Q2 2025, and down 8.32% quarter-over-quarter from $28.4 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Assets Average (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Assets Average for 7 consecutive years, with $26.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average rose 48.49% year-over-year to $26.1 million; the trailing twelve-month figure through Jun 2026 stood at $26.1 million (up 48.49% YoY), and the FY2025 full-year result was $21.8 million, down 10.81% from the prior year.
  • Assets Average eased to $26.1 million in Q2 2026 per TAOX's latest filing, from $28.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $37.6 million in Q1 2023 and bottomed at $16.5 million in Q1 2025.
  • Historically, Assets Average has averaged $27.7 million across 5 years, with a median of $28.7 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Assets Average jumped 193.87% in 2022, then tumbled 45.36% in 2025.
  • Over 5 years, Assets Average stood at $33.0 million in 2022, then slipped by 3.77% to $31.7 million in 2023, then tumbled by 36.1% to $20.3 million in 2024, then advanced by 8.96% to $22.1 million in 2025, then climbed by 18.0% to $26.1 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $26.1 million, $28.4 million, and $22.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn 5.51 Bn
10 TAO Synergies 30.79 Mn 30.79 Mn - 26.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.08 Mn
Mar 31, 2026 28.44 Mn
Dec 31, 2025 22.10 Mn
Sep 30, 2025 19.08 Mn
Jun 30, 2025 17.56 Mn
Mar 31, 2025 16.53 Mn
Dec 31, 2024 20.28 Mn
Sep 30, 2024 25.61 Mn
Jun 30, 2024 28.89 Mn
Mar 31, 2024 30.26 Mn
Dec 31, 2023 31.74 Mn
Sep 30, 2023 32.90 Mn
Jun 30, 2023 34.98 Mn
Mar 31, 2023 37.57 Mn
Dec 31, 2022 32.98 Mn
Sep 30, 2022 28.46 Mn
Jun 30, 2022 30.97 Mn
Mar 31, 2022 33.94 Mn
Dec 31, 2021 33.94 Mn
Sep 30, 2021 32.66 Mn